Versicor/Biosearch Italia: Merging as Equals

Versicor had wanted to buy its partner Biosearch Italia for more than a year prior to July's deal. But it had to wait for its market capitalization to fall closer in line with that of the Italian biotech so that the transaction could qualify as a "merger of equals."

More from Global Vision

More from In Vivo